Literature DB >> 26374435

Prescription Opioid Use Among Seriously Mentally Ill Veterans Nationally in the Veterans Health Administration.

Nickie Mathew1,2, Robert A Rosenheck3.   

Abstract

Frequent prescription opioid use has been recognized as a growing problem but there have been no studies specifically among veterans with serious mental illness (SMI). National data from the Veterans Health Administration (VHA) during Fiscal Year 2012 show that VHA patients with SMI receive more opioid prescriptions than other veterans. Additionally, high numbers of opioid prescriptions is associated with greater use of anxiolytics/sedative-hypnotics, drug dependence and COPD-all of which pose an increased risk of respiratory depression and falls and warrant substantial caution and improved coordination between mental health and non-mental health prescribers to evaluate risk-benefit tradeoffs.

Entities:  

Keywords:  Anxiolytics; Prescription opioids; Serious mental illness; Veterans

Mesh:

Substances:

Year:  2015        PMID: 26374435     DOI: 10.1007/s10597-015-9939-4

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  25 in total

Review 1.  Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.

Authors:  Bridget A Martell; Patrick G O'Connor; Robert D Kerns; William C Becker; Knashawn H Morales; Thomas R Kosten; David A Fiellin
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

2.  Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain.

Authors:  Mark J Edlund; Diane Steffick; Teresa Hudson; Katherine M Harris; Mark Sullivan
Journal:  Pain       Date:  2007-04-20       Impact factor: 6.961

3.  Pharmaceutical overdose deaths, United States, 2010.

Authors:  Christopher M Jones; Karin A Mack; Leonard J Paulozzi
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

4.  Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit.

Authors:  H G Rincon; M Granados; J Unutzer; M Gomez; R Duran; M Badiel; C Salas; J Martinez; J Mejia; C Ordoñez; N Florez; F Rosso; P Echeverri
Journal:  Psychosomatics       Date:  2001 Sep-Oct       Impact factor: 2.386

5.  Characteristics of opioid prescriptions in 2009.

Authors:  Nora D Volkow; Thomas A McLellan; Jessica H Cotto; Meena Karithanom; Susan R B Weiss
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

6.  Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain.

Authors:  Benjamin J Morasco; Jonathan P Duckart; Thomas P Carr; Richard A Deyo; Steven K Dobscha
Journal:  Pain       Date:  2010-12       Impact factor: 6.961

Review 7.  Integrating physical activity into mental health services for persons with serious mental illness.

Authors:  Caroline R Richardson; Guy Faulkner; Judith McDevitt; Gary S Skrinar; Dori S Hutchinson; John D Piette
Journal:  Psychiatr Serv       Date:  2005-03       Impact factor: 3.084

8.  Pain associated with specific anxiety and depressive disorders in a nationally representative population sample.

Authors:  Katja Beesdo; Frank Jacobi; Jürgen Hoyer; Nancy C P Low; Michael Höfler; Hans-Ulrich Wittchen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-10       Impact factor: 4.328

9.  Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain.

Authors:  Steven K Dobscha; Benjamin J Morasco; Jonathan P Duckart; Tara Macey; Richard A Deyo
Journal:  Clin J Pain       Date:  2013-02       Impact factor: 3.442

10.  Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department.

Authors:  Barth L Wilsey; Scott M Fishman; Alexander Tsodikov; Christine Ogden; Ingela Symreng; Amy Ernst
Journal:  Pain Med       Date:  2008-02-05       Impact factor: 3.750

View more
  1 in total

1.  Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness.

Authors:  Ashli Owen-Smith; Christine Stewart; Musu M Sesay; Sheryl M Strasser; Bobbi Jo Yarborough; Brian Ahmedani; Lisa R Miller-Matero; Stephen C Waring; Irina V Haller; Beth E Waitzfelder; Stacy A Sterling; Cynthia I Campbell; Rulin C Hechter; John E Zeber; Laurel A Copeland; Jeffrey F Scherrer; Rebecca Rossom; Greg Simon
Journal:  BMC Psychiatry       Date:  2020-01-31       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.